3SBio will grant Pfizer exclusive global rights, not including China, to develop, manufacture and commercialize SSGJ-707, a ...

3SBio will receive an upfront payment of $1.25B and is eligible to receive milestone payments associated with certain development, regulatory and commercial milestones up to $4.8B as well as tiered ...

The World Health Organization's member countries have approved an agreement to better prevent, prepare for and respond to ...

Members of the World Health Organization adopted a landmark agreement on Tuesday on how to prepare for future pandemics ...

Pfizer Inc. announced Monday it has secured exclusive global rights, excluding China, to 3SBio Inc.'s bispecific antibody ...

Pfizer just penned a $6 billion licensing deal with China's 3SBio to develop and commercialize a cancer drug, SSGJ-707. The ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international alliances.